Spikevax shot approved for kids aged 6 to 11.
Moderna says Health Canada has approved its COVID-19 vaccine for use in children between the ages of 6 and 11.
The Spikevax shot was recently cleared for kids in the same age group in Australia and the EU.
The company is awaiting a decision from the FDA on the use of vaccine for children aged 12 to 17 in the United States.
Health Canada has approved two half doses for kids aged 6 to 11, taken one month apart.
Last year, Moderna said the vaccine generated virus-neutralizing antibodies for children in that age group.
Temporary Patio Program Turned Down
Port Colborne Trying to Reduce Water Rates
Province Supporting Niagara Festivals
2nd Suspect Arrested in Vape Store Theft
Man Charged with Sexual Assault
Public Health Asking for $42-Mill
Fort Erie Increasing Pressure on Niagara Health
150th Birthday Celebrated at Montebello Park